{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:28:04Z","timestamp":1791070084217,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,15]]},"DOI":"10.1093\/hmg\/ddg363","type":"journal-article","created":{"date-parts":[[2003,11,27]],"date-time":"2003-11-27T00:30:44Z","timestamp":1069893044000},"page":"3385-3395","source":"Crossref","is-referenced-by-count":245,"title":["Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease"],"prefix":"10.1093","volume":"12","author":[{"given":"Jessica","family":"Caprioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Castelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bucchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bettinaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bresin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Pianetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Brioschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Daina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,12,15]]},"reference":[{"key":"key\n\t\t\t\t20170522150631_DDG363C1","doi-asserted-by":"crossref","unstructured":"Ruggenenti, P., Noris, M. and Remuzzi, G. (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int., 60, 831\u2013846.","DOI":"10.1046\/j.1523-1755.2001.060003831.x"},{"key":"key\n\t\t\t\t20170522150631_DDG363C2","unstructured":"Ruggenenti, P., Noris, M. and Remuzzi, G. (2003) Thrombotic microangiopathies. In Brady, H. R. and Wilcox, C. S. (eds), Therapy in Nephrology and Hypertension: a Companion to Brenner and Rector's The Kidney. W.B. Saunders, Philadelphia, PA."},{"key":"key\n\t\t\t\t20170522150631_DDG363C3","unstructured":"Kaplan, B.S., Meyers, K.E. and Schulman, S.L. (1998) The patogenesis and treatment of hemolytic uremic syndrome. J. Am. Soc. Nephrol., 9, 1126\u20131133."},{"key":"key\n\t\t\t\t20170522150631_DDG363C4","doi-asserted-by":"crossref","unstructured":"Fitzpatrick, M.M., Walters, M.D.S. and Trompeter, R.S. (1993) Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J. Pediatr., 122, 532\u2013537.","DOI":"10.1016\/S0022-3476(05)83531-0"},{"key":"key\n\t\t\t\t20170522150631_DDG363C5","doi-asserted-by":"crossref","unstructured":"Proesmans, W. (1996) Typical and atypical hemolytic uremic syndrome. Kidney Blood Press. Res., 19, 205\u2013208.","DOI":"10.1159\/000174075"},{"key":"key\n\t\t\t\t20170522150631_DDG363C6","doi-asserted-by":"crossref","unstructured":"Neuhaus, T.J., Calonder, S. and Leumann, E.P. (1997) Heterogeneity of atypical hemolytic uremic syndrome. Arch. Dis. Child., 76, 518\u2013521.","DOI":"10.1136\/adc.76.6.518"},{"key":"key\n\t\t\t\t20170522150631_DDG363C7","doi-asserted-by":"crossref","unstructured":"Kaplan, B.S. and Kaplan, P. (1992) Hemolytic Uremic Syndrome in Families. Marcel Dekker, New York.","DOI":"10.1097\/00008480-199204000-00010"},{"key":"key\n\t\t\t\t20170522150631_DDG363C8","doi-asserted-by":"crossref","unstructured":"Berns, J.S., Kaplan, B.S., Mackow, R.C. and Hefter, L.G. (1992) Inherited hemolytic uremic syndrome in adults. Am. J. Kidney Dis., 19, 331\u2013334.","DOI":"10.1016\/S0272-6386(12)80449-5"},{"key":"key\n\t\t\t\t20170522150631_DDG363C9","doi-asserted-by":"crossref","unstructured":"Kirchner, K.A., Smith, R.M., Gockerman, J.P. and Luke, R.G. (1982) Hereditary thrombotic thrombocytopenic purpura: microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency occurring in consecutive generations. Nephron, 30, 28\u201330.","DOI":"10.1159\/000182427"},{"key":"key\n\t\t\t\t20170522150631_DDG363C10","doi-asserted-by":"crossref","unstructured":"Bergstein, J., Michael, A. Jr, Kjellstrand, C., Simmons, R. and Najarian, J. (1974) Hemolytic\u2013uremic syndrome in adult sisters. Transplantation, 17, 487\u2013489.","DOI":"10.1097\/00007890-197405000-00007"},{"key":"key\n\t\t\t\t20170522150631_DDG363C11","unstructured":"Pirson, Y., Lefebvre, C., Arnout, C. and de Strihou, C.Y. (1997) Hemolytic uremic syndrome in three adult siblings: a familial study and evolution. Clin. Nephrol., 28, 250\u2013255."},{"key":"key\n\t\t\t\t20170522150631_DDG363C12","doi-asserted-by":"crossref","unstructured":"Carreras, L., Romero, R., Requesens, C., Oliver, A.J., Carrera, M., Clavo, M. and Alsina, J. (1981) Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3, B7 haplotype. J. Am. Med. Assoc., 245, 602\u2013604.","DOI":"10.1001\/jama.1981.03310310044021"},{"key":"key\n\t\t\t\t20170522150631_DDG363C13","doi-asserted-by":"crossref","unstructured":"Pichette, V., Qu\u00e9rin, S., Sch\u00fcrch, W., Brun, G., Lehner-Netsch, G. and Delaghe, J-M. (1994) Familial hemolytic\u2013uremic syndrome and homozygous factor H deficiency. Am. J. Kidney Dis., 26, 936\u2013941.","DOI":"10.1016\/S0272-6386(12)81065-1"},{"key":"key\n\t\t\t\t20170522150631_DDG363C14","unstructured":"Thompson, R.A. and Winterborn, M.H. (1981) Hypocomplementaemia due to a genetic deficiency of \u03b11H globulin. Clin. Exp. Immunol., 46, 110\u2013119."},{"key":"key\n\t\t\t\t20170522150631_DDG363C15","unstructured":"Rougier, N., Kazatchkine, M.D., Rougier, J.-P., Fremeaux-Bacchi, V., Blouin, J., Deschenes, G., Soto, B., Baudouin, V., Pautard, B., Proesmans, W. et al. (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome. J. Am. Soc. Nephrol., 9, 2318\u20132326."},{"key":"key\n\t\t\t\t20170522150631_DDG363C16","doi-asserted-by":"crossref","unstructured":"Warwicker, P., Goodship, T.H.J., Donne, R.L., Pirson, Y., Nicholls, A., Ward, R.M., Turnpenny, P. and Goodship, J.A. (1998) Genetic studies into inherited and sporadic haemolytic uraemic syndrome. Kidney Int., 53, 836\u2013844.","DOI":"10.1111\/j.1523-1755.1998.00824.x"},{"key":"key\n\t\t\t\t20170522150631_DDG363C17","doi-asserted-by":"crossref","unstructured":"Caprioli, J., Bettinaglio, P., Zipfel, P.F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G. and Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J. Am. Soc. Nephrol., 12, 297\u2013307.","DOI":"10.1681\/ASN.V122297"},{"key":"key\n\t\t\t\t20170522150631_DDG363C18","doi-asserted-by":"crossref","unstructured":"Richard, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A. and Goodship, T.H.J. (2001) Factor H mutations in hemolitic uremic syndrome cluster in exons 18\u201320, a domain important for host cell recognition. Am. J. Hum. Genet., 68, 485\u2013490.","DOI":"10.1086\/318203"},{"key":"key\n\t\t\t\t20170522150631_DDG363C19","doi-asserted-by":"crossref","unstructured":"Perez-Caballero, D., Gonzalez-Rubio, C., Gallardo, M.E., Vera, M., Lopez-Trascasa, M., Rodriguez de Cordoba, S. and Sanchez-Corral, P. (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am. J. Hum. Genet., 68, 478\u2013484.","DOI":"10.1086\/318201"},{"key":"key\n\t\t\t\t20170522150631_DDG363C20","doi-asserted-by":"crossref","unstructured":"Remuzzi, G., Ruggenenti, P., Codazzi, D., Noris, M., Caprioli, J., Locatelli, G. and Gridelli, B. (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet, 359, 1671\u20131672.","DOI":"10.1016\/S0140-6736(02)08560-4"},{"key":"key\n\t\t\t\t20170522150631_DDG363C21","doi-asserted-by":"crossref","unstructured":"Neumann H.P., Salzmann M., Bohnert-Iwan B., Mannuelian T., Skerka C., Lenka D., Bender B.U., Cybulla M., Riegler P., Konigsrainer A. et al. (2003) Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study in German speaking countries. J. Med. Genet., 40, 676\u2013681.","DOI":"10.1136\/jmg.40.9.676"},{"key":"key\n\t\t\t\t20170522150631_DDG363C22","doi-asserted-by":"crossref","unstructured":"Furlan, M., Robles, R. and Lammle, B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood, 87, 4223\u20134234.","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223"},{"key":"key\n\t\t\t\t20170522150631_DDG363C23","doi-asserted-by":"crossref","unstructured":"Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniac, D.R., Strak, K.R., Gruppo, R. et al. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 475\u2013476.","DOI":"10.1038\/35097008"},{"key":"key\n\t\t\t\t20170522150631_DDG363C24","doi-asserted-by":"crossref","unstructured":"Kokame, K., Matsumoto, M. and Soejima, K. (2002) Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc. Natl Acad. Sci. USA, 99, 11902\u201311907.","DOI":"10.1073\/pnas.172277399"},{"key":"key\n\t\t\t\t20170522150631_DDG363C25","doi-asserted-by":"crossref","unstructured":"Antoine, G., Zimmermann, K., Plaimauer, B., Grillowitzer, M., Studt, J-D., Lammle, B. and Scheiflinger, F. (2003) ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13. Br. J. Haematol., 120, 821\u2013824.","DOI":"10.1046\/j.1365-2141.2003.04183.x"},{"key":"key\n\t\t\t\t20170522150631_DDG363C26","doi-asserted-by":"crossref","unstructured":"Savasan, S., Lee, S-K., Ginsburg, D. and Tsai, H-M. (2003) ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity. Blood, 101, 4449\u20134451.","DOI":"10.1182\/blood-2002-12-3796"},{"key":"key\n\t\t\t\t20170522150631_DDG363C27","doi-asserted-by":"crossref","unstructured":"Schneppenheim, R., Budde, U., Oyen, F., Angerhaus, D., Aumann, V., Drewke, E., Hassenpflug, W., Haberle, J., Kentouche, K., Kohne, E. et al. (2003) von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood, 101, 1845\u20131850.","DOI":"10.1182\/blood-2002-08-2399"},{"key":"key\n\t\t\t\t20170522150631_DDG363C28","doi-asserted-by":"crossref","unstructured":"Assink, K., Schiphorst, R., Allford, S., Karpman, D., Etzioni, A., Brichard, B., van de Kar, N., Monnens, L. and van den Heuvel, L. (2003) Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. Kidney Int., 63, 1995\u20131999.","DOI":"10.1046\/j.1523-1755.63.6s.1.x"},{"key":"key\n\t\t\t\t20170522150631_DDG363C29","doi-asserted-by":"crossref","unstructured":"Remuzzi, G., Galbusera, M., Noris, M., Canciani, M.T., Daina, E., Bresin, E., Contaretti, S., Caprioli, J., Gamba, S., Ruggenenti, P. et al. (2002) von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood, 100, 778\u2013785.","DOI":"10.1182\/blood-2001-12-0166"},{"key":"key\n\t\t\t\t20170522150631_DDG363C30","doi-asserted-by":"crossref","unstructured":"Veyradier, A., Obert, B., Haddad, E., Cloarec, S., Nivet, H., Foulard, M., Lesure, F., Delattre, P., Lakhdari, M., Meyer, D. et al. (2003) Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS13) activity in a subgroup of children with atypical hemolytic-uremic syndrome. J. Pediatr., 142, 310\u2013317.","DOI":"10.1067\/mpd.2003.79"},{"key":"key\n\t\t\t\t20170522150631_DDG363C31","doi-asserted-by":"crossref","unstructured":"Warwicker, P., Goodship, T.H.J. and Goodship, J.A. (1997) Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics, 46, 437\u2013438.","DOI":"10.1007\/s002510050300"},{"key":"key\n\t\t\t\t20170522150631_DDG363C32","doi-asserted-by":"crossref","unstructured":"Meri, S. and Pangburn, M.K. (1990) Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid\/polianion binding site on factor H. Proc. Natl Acad. Sci. USA, 87, 3982\u20133986.","DOI":"10.1073\/pnas.87.10.3982"},{"key":"key\n\t\t\t\t20170522150631_DDG363C33","doi-asserted-by":"crossref","unstructured":"Kazatchkine, M.D., Fearon, D.T. and Austen, K.F. (1979) Human alternative complement pathway: membrane-associated sialic acid regulates the competiton between B and BIH for cell-bound C3b. J. Immunol., 122, 75.","DOI":"10.4049\/jimmunol.122.1.75"},{"key":"key\n\t\t\t\t20170522150631_DDG363C34","doi-asserted-by":"crossref","unstructured":"Taylor, C.M. (2001) Complement factor H and the haemolytic uraemic syndrome. Lancet, 358, 1200\u20131202.","DOI":"10.1016\/S0140-6736(01)06339-5"},{"key":"key\n\t\t\t\t20170522150631_DDG363C35","doi-asserted-by":"crossref","unstructured":"Zipfel, P.F. and Skerka, C. (1994) Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today, 15, 121\u2013126.","DOI":"10.1016\/0167-5699(94)90155-4"},{"key":"key\n\t\t\t\t20170522150631_DDG363C36","doi-asserted-by":"crossref","unstructured":"Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H.P.H. and Remuzzi, G. (2003) Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J. Clin. Invest., 111, 1181\u20131190.","DOI":"10.1172\/JCI16651"},{"key":"key\n\t\t\t\t20170522150631_DDG363C37","doi-asserted-by":"crossref","unstructured":"Pangburn, M.K. (2002) Cutting edge: localization of the host recognition funtions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J. Immunol., 169, 4702\u20134706.","DOI":"10.4049\/jimmunol.169.9.4702"},{"key":"key\n\t\t\t\t20170522150631_DDG363C38","doi-asserted-by":"crossref","unstructured":"Sanchez-Corral, P., Perez-Caballero, D., Huarte, O., Simckes, A.M., Goicoechea, E., Lopez-Trascasa, M. and Rodriguez de Cordoba, S. (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am. J. Hum. Genet., 71, 1285\u20131295.","DOI":"10.1086\/344515"},{"key":"key\n\t\t\t\t20170522150631_DDG363C39","unstructured":"Noris, M., Casiraghi, F., Ruiz Torres, M.P., Caprioli, J., Galbusera, M. and Remuzzi, G. (2001) Serum from patients with recurrent HUS and TTP induces endothelial damage and thrombus formation: role of complememt. Mol. Immunol., 38, 113\u2013114 (Abstract)."},{"key":"key\n\t\t\t\t20170522150631_DDG363C40","doi-asserted-by":"crossref","unstructured":"Landau, D., Shalev, H., Levy-Finer, G., Polonsky, A., Segev, Y. and Katchko, L. (2001) Familial hemolytic uremic syndrome associated with complement factor H deficiency. J. Pediatr., 138, 412\u2013417.","DOI":"10.1067\/mpd.2001.112649"},{"key":"key\n\t\t\t\t20170522150631_DDG363C41","doi-asserted-by":"crossref","unstructured":"Azevedo-Martins, A.K., Lortz, S., Lenzen, S., Curi, R., Eizirik, D.L. and Tiedge, M. (2003) Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes, 52, 93\u2013101.","DOI":"10.2337\/diabetes.52.1.93"},{"key":"key\n\t\t\t\t20170522150631_DDG363C42","doi-asserted-by":"crossref","unstructured":"Dawson, S.J., Wiman, B., Hamsten, A., Green, F., Humphries, S. and Henney, A.M. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J. Biol. Chem., 168, 10739\u201310745.","DOI":"10.1016\/S0021-9258(18)82047-6"},{"key":"key\n\t\t\t\t20170522150631_DDG363C43","doi-asserted-by":"crossref","unstructured":"Friese, M.A., Hellwage, J., Jokiranta, T.S., Meri, S., Peter, H.H., Eibel, H. and Zipfel, P.F. (1999) FHL-1\/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol., 36, 809\u2013818.","DOI":"10.1016\/S0161-5890(99)00101-7"},{"key":"key\n\t\t\t\t20170522150631_DDG363C44","doi-asserted-by":"crossref","unstructured":"Hegasy, G., Manuelian, T., Hogasen, K., Jansen, J.H. and Zipfel, P.F. (2002) The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II. Am. J. Pathol., 161, 2027\u20132034.","DOI":"10.1016\/S0002-9440(10)64481-1"},{"key":"key\n\t\t\t\t20170522150631_DDG363C45","doi-asserted-by":"crossref","unstructured":"Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J. and Botto, M. (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet., 31, 424\u2013428.","DOI":"10.1038\/ng912"},{"key":"key\n\t\t\t\t20170522150631_DDG363C46","doi-asserted-by":"crossref","unstructured":"Noris, M., Ruggenenti, P., Perna, A., Orisio, S., Caprioli, J., Skerka, C., Vasile, B., Zipfel, P.F., Remuzzi, G. on behalf of the Italian Registry of Familial and Recurrent HUS\/TTP (1999) Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J. Am. Soc. Nephrol., 10, 281\u2013293.","DOI":"10.1681\/ASN.V102281"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/12\/24\/3385\/17240696\/ddg363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:57:51Z","timestamp":1704985071000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddg363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,15]]},"references-count":46,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2003,12,15]]},"published-print":{"date-parts":[[2003,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddg363","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12,15]]}}}